A lawsuit filed last week accuses Johnson & Johnson of conspiring with pharmaceutical consultant Omnicare in an effort to push J&J drugs on nursing home residents, and violating federal Medicaid laws in the process.
As a result of the scheme, "residents were overcharged for their medications, had additional medications administered and were unlawfully switched to Johnson & Johnson drugs," all in the name of increasing revenue, according to the lawsuit.'
Read more...
Showing posts with label Johnson and Johnson. Show all posts
Showing posts with label Johnson and Johnson. Show all posts
Sunday, April 11, 2010
Thursday, January 21, 2010
Johnson & Johnson Engaged in Elaborate Drug Profit Kickback Scheme, says Dept. of Justice Lawsuit
Drug maker Johnson & Johnson paid tens of millions of dollars in kickbacks to nursing home pharmacies in order to boost the sale of its drugs, says a Justice Department lawsuit.
The payments were often disguised as grants or "educational funding," says the lawsuit, and they were directed to Omnicare, a prominent nursing home pharmacy company.
The elaborate kickback scheme caused sales of Johnson & Johnson drugs to skyrocket. Sales of the antipsychotic drug Risperdal, for example, helped J&J drug purchases from Omnicare nearly triple from $100 million to $280 million a year.'
Read more...
The payments were often disguised as grants or "educational funding," says the lawsuit, and they were directed to Omnicare, a prominent nursing home pharmacy company.
The elaborate kickback scheme caused sales of Johnson & Johnson drugs to skyrocket. Sales of the antipsychotic drug Risperdal, for example, helped J&J drug purchases from Omnicare nearly triple from $100 million to $280 million a year.'
Read more...
Subscribe to:
Comments (Atom)